Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07612696 · ClinicalTrials.gov registry record · NA
Impact of Electronic Cigarette Temperature and Solvent on Biomarkers
A NA study, sponsored by Milton S. Hershey Medical Center.
- Not yet
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT07612696 is a NA study that has not yet begun recruiting, run by Milton S. Hershey Medical Center. The registered enrollment target is 50 participants.
The verdict
NCT07612696, a NA study, has not yet begun recruiting, sponsored by Milton S. Hershey Medical Center.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
This project seeks to determine how e-cigarette (EC) physical design features, including those that allow the user to manipulate the quality and quantity of aerosols, affect exposure and toxicity from oxidants and other aerosol constituents.
Interventions
- OTHER High temperature wattage setting on electronic cigarette
- OTHER Low temperature wattage setting on electronic cigarette
- OTHER High concentration of Propylene Glycol
- OTHER Low concentration of Propylene Glycol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2026-07-15 |
| Est. Completion | 2028-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07612696
The ClinicalTrials.gov registry entry for NCT07612696 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Milton S. Hershey Medical Center, which has 396 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which High temperature wattage setting on electronic cigarette is the first listed.
NCT07612696 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07612696 about?
NCT07612696 is a clinical study titled "Impact of Electronic Cigarette Temperature and Solvent on Biomarkers". This project seeks to determine how e-cigarette (EC) physical design features, including those that allow the user to manipulate the quality and quantity of aerosols, affect exposure and toxicity from oxidants and other aerosol constituents.
What is the current status of trial NCT07612696?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2026-07-15. Estimated completion is 2028-12.
What interventions are being tested in trial NCT07612696?
The interventions under investigation include: High temperature wattage setting on electronic cigarette (OTHER), Low temperature wattage setting on electronic cigarette (OTHER), High concentration of Propylene Glycol (OTHER), Low concentration of Propylene Glycol (OTHER).
Who is sponsoring clinical trial NCT07612696?
This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.